GF
Genie develops a discovery platform leveraging machine learning and omics to identify novel molecular biomarkers for reproductive health. This platform powers a non-invasive diagnostic that analyzes molecular biomarkers in the uterine lining using menstrual blood. The company aims to improve fertility screening by providing data on endometrial health, a factor often overlooked in current fertility assessments.
Updated 3 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Product
Features
- Genie develops a discovery platform leveraging machine learning and omics to identify novel molecular biomarkers for reproductive health. This platform powers a non-invasive diagnostic that analyzes molecular biomarkers in the uterine lining using menstrual blood. The company aims to improve fertility screening by providing data on endometrial health, a factor often overlooked in current fertility assessments.